{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T00:21:24Z","timestamp":1760833284988,"version":"build-2065373602"},"reference-count":108,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.breast.2005.08.027","type":"journal-article","created":{"date-parts":[[2005,10,25]],"date-time":"2005-10-25T08:44:45Z","timestamp":1130229885000},"page":"509-519","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Biological variables and prognosis of DCIS"],"prefix":"10.1016","volume":"14","author":[{"given":"Marc J.","family":"van de Vijver","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2005.08.027_bib1","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1053\/crad.2001.0962","article-title":"How significant is detection of ductal carcinoma in situ in a breast screening programme?","volume":"57","author":"Kessar","year":"2002","journal-title":"Clin Radiol"},{"key":"10.1016\/j.breast.2005.08.027_bib2","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/S0140-6736(98)07412-1","article-title":"16-year mortality from breast cancer in the UK trial of early detection of breast cancer","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.breast.2005.08.027_bib3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1054\/brst.2000.0212","article-title":"Nationwide breast cancer screening programme fully implemented in the Netherlands","volume":"10","author":"Fracheboud","year":"2001","journal-title":"Breast"},{"key":"10.1016\/j.breast.2005.08.027_bib4","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1093\/jnci\/94.20.1546","article-title":"Detection of ductal carcinoma in situ in women undergoing screening mammography","volume":"94","author":"Ernster","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.breast.2005.08.027_bib5","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/jnci\/djh164","article-title":"Ductal carcinoma in situ, complexities and challenges","volume":"96","author":"Leonard","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.breast.2005.08.027_bib6","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/0140-6736(90)90747-S","article-title":"Extent, distribution and mammographic\/histological correlations of breast ductal carcinoma in situ","volume":"335","author":"Holland","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.breast.2005.08.027_bib7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1023\/B:BREA.0000018434.04960.02","article-title":"Ductal in situ component and prognosis in invasive mammary carcinoma","volume":"84","author":"Millis","year":"2004","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2005.08.027_bib8","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1200\/JCO.2001.19.8.2263","article-title":"Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853","volume":"19","author":"Bijker","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2005.08.027_bib9","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0093-7754(01)90133-2","article-title":"Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the national surgical adjuvant breast and bowel project experience","volume":"28","author":"Fisher","year":"2001","journal-title":"Semin Oncol"},{"key":"10.1016\/j.breast.2005.08.027_bib10","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/(SICI)1097-0142(19990801)86:3<429::AID-CNCR11>3.0.CO;2-Y","article-title":"Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight-year update of Protocol B-17: intraductal carcinoma","volume":"86","author":"Fisher","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2005.08.027_bib11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0140-6736(03)13859-7","article-title":"Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial","volume":"362","author":"Houghton","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.breast.2005.08.027_bib12","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1056\/NEJM199905133401902","article-title":"The influence of margin width on local control of ductal carcinoma in situ of the breast","volume":"340","author":"Silverstein","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.breast.2005.08.027_bib13","first-page":"202","article-title":"A critical appraisal of existing classification systems of epithelial hyperplasia and in situ neoplasia of the breast with proposals for future methods of categorization: where are we going?","volume":"16","author":"Ellis","year":"1999","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.breast.2005.08.027_bib14","first-page":"1056","article-title":"Consistency achieved by 23 European pathologists in categorizing ductal carcinoma in situ of the breast using five classifications. European Commission Working Group on Breast Screening Pathology","volume":"29","author":"Sloane","year":"1998","journal-title":"Hum Pathol"},{"key":"10.1016\/j.breast.2005.08.027_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s004280050297","article-title":"Consistency achieved by 23 European pathologists from 12 countries in diagnosing breast disease and reporting prognostic features of carcinomas. European Commission Working Group on Breast Screening Pathology","volume":"434","author":"Sloane","year":"1999","journal-title":"Virchows Arch"},{"key":"10.1016\/j.breast.2005.08.027_bib16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0065-230X(08)60954-9","article-title":"Molecular genetics in breast cancer","volume":"61","author":"Van de Vijver","year":"1993","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.breast.2005.08.027_bib17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","article-title":"Human breast cancer: correlation of relapse and survival with amplification of the HER-2\/neu oncogene","volume":"235","author":"Slamon","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.breast.2005.08.027_bib18","first-page":"2019","article-title":"Amplification of the neu (c-erbB-2) oncogene in human mammary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene","volume":"7","author":"Van de Vijver","year":"1987","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.breast.2005.08.027_bib19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1677\/erc.0.0080047","article-title":"Histological and biological evolution of human premalignant breast disease","volume":"8","author":"Allred","year":"2001","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.breast.2005.08.027_bib20","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1002\/1097-0142(20011215)92:12<2965::AID-CNCR10156>3.0.CO;2-A","article-title":"Detection of HER-2\/neu (c-erb B-2) DNA amplification in primary breast carcinoma. Interobserver reproducibility and correlation with immunohistochemical HER-2 overexpression","volume":"92","author":"Tsuda","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2005.08.027_bib21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1053\/hupa.2002.30185","article-title":"Protein overexpression and gene amplification of c-erbB-2 in breast carcinomas: a comparative study of immunohistochemistry and fluorescence in situ hybridization of formalin-fixed, paraffin-embedded tissues","volume":"33","author":"Kobayashi","year":"2002","journal-title":"Hum Pathol"},{"key":"10.1016\/j.breast.2005.08.027_bib22","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1056\/NEJM198811103191902","article-title":"Neu-protein overexpression in breast cancer. Association with comedo-type ductal carcinoma in situ and limited prognostic value in stage II breast cancer","volume":"319","author":"Van de Vijver","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.breast.2005.08.027_bib23","first-page":"4185","article-title":"Heterogeneous expression of erbB-2 messenger RNA in human breast cancer","volume":"49","author":"King","year":"1989","journal-title":"Cancer Res"},{"key":"10.1016\/j.breast.2005.08.027_bib24","first-page":"423","article-title":"Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis","volume":"1","author":"Varley","year":"1987","journal-title":"Oncogene"},{"key":"10.1016\/j.breast.2005.08.027_bib25","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1126\/science.2470152","article-title":"Studies of the HER-2\/neu proto-oncogene in human breast and ovarian cancer","volume":"244","author":"Slamon","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.breast.2005.08.027_bib26","first-page":"3104","article-title":"Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1\/int-2 and c-erbB-2\/ear-1","volume":"49","author":"Tsuda","year":"1989","journal-title":"Cancer Res"},{"key":"10.1016\/j.breast.2005.08.027_bib27","first-page":"835","article-title":"Oncogene amplification in breast cancer","volume":"138","author":"Donovan-Peluso","year":"1991","journal-title":"J Pathol"},{"key":"10.1016\/j.breast.2005.08.027_bib28","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/0046-8177(94)90083-3","article-title":"The neu-oncogene: more than a prognostic indicator?","volume":"25","author":"De Potter","year":"1994","journal-title":"Hum Pathol"},{"key":"10.1016\/j.breast.2005.08.027_bib29","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/(SICI)1096-9896(199912)189:4<496::AID-PATH485>3.0.CO;2-D","article-title":"Genetic alterations in \u2018normal\u2019 luminal and myoepithelial cells of the breast","volume":"189","author":"Lakhani","year":"1999","journal-title":"J Pathol"},{"key":"10.1016\/j.breast.2005.08.027_bib30","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1155\/1998\/180738","article-title":"Detection of c-erbB-2 mRNAs using dig-labelled oligonucleotide probe with in situ hybridisation in human breast carcinoma: comparison with immunohistochemical results","volume":"16","author":"Ozturk","year":"1998","journal-title":"Anal Cell Pathol"},{"key":"10.1016\/j.breast.2005.08.027_bib31","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/0046-8177(90)90154-W","article-title":"Immunohistochemical demonstration of c-erbB-2 protein in mammary ductal carcinoma in situ","volume":"21","author":"Bartkova","year":"1990","journal-title":"Hum Pathol"},{"key":"10.1016\/j.breast.2005.08.027_bib32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/path.1711610104","article-title":"Immunohistochemical distribution of c-erbB-2 in in situ breast carcinoma\u2014a detailed morphological analysis","volume":"161","author":"Ramachandra","year":"1990","journal-title":"J Pathol"},{"key":"10.1016\/j.breast.2005.08.027_bib33","first-page":"1027","article-title":"The HER2 (c-erbB-2) oncogene is frequently amplified in in situ carcinomas of the breast","volume":"7","author":"Liu","year":"1992","journal-title":"Oncogene"},{"key":"10.1016\/j.breast.2005.08.027_bib34","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/sj.bjc.6693372","article-title":"Genetic alterations on chromosome 16 and 17 are important features of ductal carcinoma in situ of the breast and are associated with histologic type","volume":"81","author":"Vos","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.breast.2005.08.027_bib35","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/jcp.48.7.611","article-title":"Atypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozygosity on chromosomes 16q en 17p","volume":"48","author":"Lakhani","year":"1995","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.breast.2005.08.027_bib36","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1093\/jnci\/87.22.1694","article-title":"Characterization of extensive genetic alteration in ductal carcinoma in situ by fluorescence in situ hybridization and molecular analysis","volume":"87","author":"Murphy","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.breast.2005.08.027_bib37","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s004280050045","article-title":"Amplification units and translocation at chromosome 17q and c-erbB-2 overexpression in the pathogenesis of breast cancer","volume":"430","author":"Coene","year":"1997","journal-title":"Virchows Arch"},{"key":"10.1016\/j.breast.2005.08.027_bib38","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1200\/JCO.2000.18.18.3230","article-title":"Activation (tyrosine phosphorylation) of ErbB-2 (HER-2\/neu): a study of incidence and correlation with outcome in breast cancer","volume":"18","author":"Thor","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2005.08.027_bib39","first-page":"6667","article-title":"Active signaling by HER-2\/neu in a subpopulation of HER-2\/neu-overexpressing ductal carcinoma in situ: clinicopathological correlates","volume":"62","author":"DiGiovanna","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.breast.2005.08.027_bib40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1155\/2002\/371680","article-title":"Genetic alterations in presumptive precursor lesions of breast carcinomas","volume":"24","author":"Aubele","year":"2002","journal-title":"Anal Cell Pathol"},{"key":"10.1016\/j.breast.2005.08.027_bib41","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S0959-8049(05)80117-0","article-title":"Overexpression of the c-erbB-2 oncoprotein: why does this occur more frequently in ductal carcinoma in situ than in invasive mammary carcinoma and is this of prognostic significance?","volume":"28","author":"Barnes","year":"1992","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.breast.2005.08.027_bib42","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/ijc.2910420608","article-title":"Immunohistochemical distribution of c-erbB-2 in infiltrating and in situ breast cancer","volume":"42","author":"Gusterson","year":"1988","journal-title":"Int J Cancer"},{"key":"10.1016\/j.breast.2005.08.027_bib43","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1097\/01.MP.0000030450.20581.E3","article-title":"Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases","volume":"15","author":"Sneige","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1016\/j.breast.2005.08.027_bib44","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/jnci\/92.8.622","article-title":"Pathogenesis of Paget's disease: epidermal heregulin-alpha, motility factor, and the HER receptor family","volume":"92","author":"Schelfhout","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.breast.2005.08.027_bib45","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1097\/00129039-200306000-00005","article-title":"Assessment of Her-2\/Neu status by immunohistochemistry and fluorescence in situ hybridization in mammary Paget disease and underlying carcinoma","volume":"11","author":"Anderson","year":"2003","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1016\/j.breast.2005.08.027_bib46","first-page":"285","article-title":"Amplification of the int-2 gene in primary human breast tumors","volume":"2","author":"Lidereau","year":"1988","journal-title":"Oncogene Res"},{"key":"10.1016\/j.breast.2005.08.027_bib47","first-page":"1389","article-title":"Proto-oncogene amplification and human breast tumor phenotype","volume":"4","author":"Adnane","year":"1989","journal-title":"Oncogene"},{"key":"10.1016\/j.breast.2005.08.027_bib48","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0277-5379(90)90009-I","article-title":"Gene amplification on chromosome band 11q13 and oestrogen receptor status in breast cancer","volume":"26","author":"Fantl","year":"1990","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.breast.2005.08.027_bib49","first-page":"147","article-title":"BCL-1 participates in the 11q13 amplification found in breast cancer","volume":"5","author":"Theillet","year":"1990","journal-title":"Oncogene"},{"key":"10.1016\/j.breast.2005.08.027_bib50","first-page":"439","article-title":"D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1","volume":"6","author":"Lammie","year":"1991","journal-title":"Oncogene"},{"key":"10.1016\/j.breast.2005.08.027_bib51","first-page":"5229","article-title":"Amplification of genes within the chromosome 11q13 region is indicative of poor prognosis in patients with operable breast cancer","volume":"52","author":"Schuuring","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/j.breast.2005.08.027_bib52","first-page":"161","article-title":"Amplification of CCND1 and expression of its protein product, cyclin D1, in ductal carcinoma in situ of the breast","volume":"151","author":"Simpson","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1016\/j.breast.2005.08.027_bib53","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/(SICI)1096-9896(199902)187:3<279::AID-PATH240>3.0.CO;2-C","article-title":"Cyclin D1 gene amplification and overexpression are present in ductal carcinoma in situ of the breast","volume":"187","author":"Vos","year":"1999","journal-title":"J Pathol"},{"key":"10.1016\/j.breast.2005.08.027_bib54","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0959-8049(05)80129-7","article-title":"Prevalence of amplification of the oncogenes c-myc, HER2\/neu, and int-2 in one thousand human breast tumours: correlation with steroid receptors","volume":"28","author":"Berns","year":"1992","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.breast.2005.08.027_bib55","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/ijc.2910570311","article-title":"Cyclin D1 protein expression and function in human breast cancer","volume":"57","author":"Bartkova","year":"1994","journal-title":"Int J Cancer"},{"key":"10.1016\/j.breast.2005.08.027_bib56","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0378-1119(94)00562-7","article-title":"The involvement of the chromosome 11q13 region in human malignancies: cyclin D1 and EMS1 are two new candidate oncogenes\u2014a review","volume":"159","author":"Schuuring","year":"1995","journal-title":"Gene"},{"key":"10.1016\/j.breast.2005.08.027_bib57","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0092-8674(00)81879-6","article-title":"CDK-independent activation of estrogen receptor by cyclin D1","volume":"88","author":"Zwijsen","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.breast.2005.08.027_bib58","first-page":"847","article-title":"Cyclin D1 protein is overexpressed in hyperplasia and intraductal carcinoma of the breast","volume":"4","author":"Alle","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.breast.2005.08.027_bib59","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/nm1295-1257","article-title":"Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions","volume":"1","author":"Weinstat-Saslow","year":"1995","journal-title":"Nat Med"},{"key":"10.1016\/j.breast.2005.08.027_bib60","first-page":"3003","article-title":"Prognostic value of TP53 protein accumulation in human primary breast cancer: an analysis by luminometric immunoassay on 1491 tumor cytosols","volume":"17","author":"Berns","year":"1997","journal-title":"Anticancer Res"},{"key":"10.1016\/j.breast.2005.08.027_bib61","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/(SICI)1098-2264(199607)16:3<170::AID-GCC3>3.0.CO;2-W","article-title":"TP53 and MYC gene alterations independently predict poor prognosis in breast cancer patients","volume":"16","author":"Berns","year":"1996","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.breast.2005.08.027_bib62","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/path.1385","article-title":"Association of C-MYC amplification with progression from the in situ to the invasive stage in C-MYC-amplified breast carcinomas","volume":"201","author":"Robanus-Maandag","year":"2003","journal-title":"J Pathol"},{"key":"10.1016\/j.breast.2005.08.027_bib63","first-page":"833","article-title":"The transforming potential of the c-erbB-2 protein is regulated by its autophosphorylation at the carboxyl-terminal domain","volume":"11","author":"Akiyama","year":"1991","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.breast.2005.08.027_bib64","first-page":"1107","article-title":"c-myc Amplification is a better prognostic factor than HER-2\/neu amplification in primary breast cancer","volume":"52","author":"Berns","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/j.breast.2005.08.027_bib65","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/jnci\/85.11.902","article-title":"Relationship of c-myc amplification to progression of breast cancer from in situ to invasive tumor and lymph node metastasis","volume":"85","author":"Watson","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.breast.2005.08.027_bib66","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1073\/pnas.68.4.820","article-title":"Mutation and cancer: statistical study of retinoblastoma","volume":"68","author":"Knudson","year":"1971","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.breast.2005.08.027_bib67","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nature02625","article-title":"Epigenetics in human disease and prospects for epigenetic therapy","volume":"429","author":"Egger","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.breast.2005.08.027_bib68","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/ng1097-130","article-title":"On the TRAIL from p53 to apoptosis?","volume":"17","author":"Kastan","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/j.breast.2005.08.027_bib69","first-page":"1573","article-title":"Evidence that p53 behaves as a tumor suppressor gene in sporadic breast tumours","volume":"5","author":"Prosser","year":"1990","journal-title":"Oncogene"},{"key":"10.1016\/j.breast.2005.08.027_bib70","first-page":"413","article-title":"Loss of chromosome 17p13 sequences and mutation of p53 in human breast carcinomas","volume":"6","author":"Varley","year":"1991","journal-title":"Oncogene"},{"key":"10.1016\/j.breast.2005.08.027_bib71","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1200\/JCO.1997.15.5.1916","article-title":"bcl-2, p53, and response to tamoxifen in estrogen receptor-positive metastatic breast cancer: a Southwest Oncology Group study","volume":"15","author":"Elledge","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2005.08.027_bib72","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/jnci\/90.18.1346","article-title":"erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer (see comments)","volume":"90","author":"Thor","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.breast.2005.08.027_bib73","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1126\/science.7973635","article-title":"p53 status and the efficacy of cancer therapy in vivo","volume":"266","author":"Lowe","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.breast.2005.08.027_bib74","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/nm0796-811","article-title":"Specific p53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients","volume":"2","author":"Aas","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.breast.2005.08.027_bib75","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/gcc.2870140113","article-title":"TP53 mutations and breast cancer prognosis: particularly poor survival rates for cases with mutations in the zinc-binding domains","volume":"14","author":"Borresen","year":"1995","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.breast.2005.08.027_bib76","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1023\/A:1005740222307","article-title":"Molecular pathology of breast cancer and its application to clinical management","volume":"16","author":"Walker","year":"1997","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.breast.2005.08.027_bib77","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/jnci\/93.9.700","article-title":"p53 missense mutations in microdissected high-grade ductal carcinoma in situ of the breast","volume":"93","author":"Done","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.breast.2005.08.027_bib78","first-page":"1","article-title":"Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumours without p53 mutations","volume":"54","author":"Cornelis","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.breast.2005.08.027_bib79","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/0140-6736(90)93236-I","article-title":"Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis","volume":"2","author":"Coles","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.breast.2005.08.027_bib80","first-page":"2925","article-title":"In breast cancer, amplification of the steroid receptor coactivator gene AIB1 is correlated with estrogen and progesterone receptor positivity","volume":"4","author":"Bautista","year":"1998","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.breast.2005.08.027_bib81","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1126\/science.277.5328.965","article-title":"AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer","volume":"277","author":"Anzick","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.breast.2005.08.027_bib82","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1002\/(SICI)1097-0142(19991001)86:7<1263::AID-CNCR23>3.0.CO;2-2","article-title":"P-cadherin expression in breast carcinoma indicates poor survival","volume":"86","author":"Peralta Soler","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2005.08.027_bib83","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/ijc.1208","article-title":"Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast","volume":"92","author":"Droufakou","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/j.breast.2005.08.027_bib84","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00000478-200102000-00011","article-title":"Carcinomas in situ of the breast with indeterminate features: role of E-cadherin staining in categorization","volume":"25","author":"Jacobs","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.breast.2005.08.027_bib85","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/path.1326","article-title":"The role of E-cadherin in low-grade ductal breast tumourigenesis","volume":"200","author":"Roylance","year":"2003","journal-title":"J Pathol"},{"key":"10.1016\/j.breast.2005.08.027_bib86","first-page":"1919","article-title":"E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain","volume":"13","author":"Berx","year":"1996","journal-title":"Oncogene"},{"key":"10.1016\/j.breast.2005.08.027_bib87","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/bjc.1997.523","article-title":"E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis","volume":"76","author":"Vos","year":"1997","journal-title":"Br J Cancer"},{"key":"10.1016\/j.breast.2005.08.027_bib88","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s004280050142","article-title":"Molecular characterization of intraductal breast carcinomas","volume":"432","author":"Stanta","year":"1998","journal-title":"Virchows Arch"},{"key":"10.1016\/j.breast.2005.08.027_bib89","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/2524","article-title":"High resolution analysis of DNA copy number variation using comparative genomic hybridization to microarrays","volume":"20","author":"Pinkel","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.breast.2005.08.027_bib90","first-page":"2003","article-title":"M6P\/IGF2 receptor: a candidate breast tumor suppressor gene","volume":"12","author":"Hankins","year":"1996","journal-title":"Oncogene"},{"key":"10.1016\/j.breast.2005.08.027_bib91","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2407-2-18","article-title":"Decreased expression of the mannose 6-phosphate\/insulin-like growth factor-II receptor promotes growth of human breast cancer cells","volume":"2","author":"Chen","year":"2002","journal-title":"BMC Cancer"},{"key":"10.1016\/j.breast.2005.08.027_bib93","first-page":"1301","article-title":"Analysis of changes in DNA sequence copy number by comparative genomic hybridization in archival paraffin-embedded tumor samples","volume":"145","author":"Isola","year":"1994","journal-title":"Am J Pathol"},{"key":"10.1016\/j.breast.2005.08.027_bib94","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/path.982","article-title":"Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns","volume":"195","author":"Boecker","year":"2001","journal-title":"J Pathol"},{"key":"10.1016\/j.breast.2005.08.027_bib95","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/00019606-200003000-00003","article-title":"Accumulation of chromosomal imbalances from intraductal proliferative lesions to adjacent in situ and invasive ductal breast cancer","volume":"9","author":"Aubele","year":"2000","journal-title":"Diagn Mol Pathol"},{"key":"10.1016\/j.breast.2005.08.027_bib96","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/(SICI)1097-0215(20000101)85:1<82::AID-IJC15>3.0.CO;2-S","article-title":"Extensive ductal carcinoma in situ with small foci of invasive ductal carcinoma: evidence of genetic resemblance by CGH","volume":"85","author":"Aubele","year":"2000","journal-title":"Int J Cancer"},{"key":"10.1016\/j.breast.2005.08.027_bib97","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/(SICI)1096-9896(199903)187:4<396::AID-PATH286>3.0.CO;2-L","article-title":"Comparative genomic hybridization of ductal carcinoma in situ of the breast\u2014evidence of multiple genetic pathways","volume":"187","author":"Buerger","year":"1999","journal-title":"J Pathol"},{"key":"10.1016\/j.breast.2005.08.027_bib98","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/sj.onc.1200923","article-title":"Comparative genomic hybridisation of ductal carcinoma in situ of the breast: identification of regions of DNA amplification and deletion in common with invasive breast carcinoma","volume":"14","author":"James","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.breast.2005.08.027_bib99","first-page":"1465","article-title":"Genetic changes in intraductal breast cancer detected by comparative genomic hybridization","volume":"150","author":"Kuukasjarvi","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1016\/j.breast.2005.08.027_bib100","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/jnci\/92.4.313","article-title":"Chromosomal alterations in ductal carcinomas in situ and their in situ recurrences","volume":"92","author":"Waldman","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.breast.2005.08.027_bib101","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/path.1711750207","article-title":"Loss of heterozygosity in ductal carcinoma in situ of the breast","volume":"175","author":"Stratton","year":"1995","journal-title":"J Pathol"},{"key":"10.1016\/j.breast.2005.08.027_bib102","first-page":"1653","article-title":"Frequent alterations of chromosome 1 in ductal carcinoma in situ of the breast","volume":"10","author":"Munn","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.breast.2005.08.027_bib103","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0002-9440(10)61679-3","article-title":"High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss","volume":"159","author":"Maitra","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.breast.2005.08.027_bib104","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/path.1711760104","article-title":"Mutation at chromosome 11q23 in human non-familial breast cancer: a microdissection microsatellite analysis","volume":"176","author":"Koreth","year":"1995","journal-title":"J Pathol"},{"key":"10.1016\/j.breast.2005.08.027_bib105","first-page":"5260","article-title":"Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast","volume":"56","author":"Fujii","year":"1996","journal-title":"Cancer Res"},{"key":"10.1016\/j.breast.2005.08.027_bib106","first-page":"3399","article-title":"Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q","volume":"55","author":"Radford","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.breast.2005.08.027_bib107","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1056\/NEJMoa021967","article-title":"A gene-expression signature as a predictor of survival in breast cancer","volume":"347","author":"Van de Vijver","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.breast.2005.08.027_bib108","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1073\/pnas.0931261100","article-title":"Gene expression profiles of human breast cancer progression","volume":"100","author":"Ma","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.breast.2005.08.027_bib109","article-title":"Micorarray analysis of formalin fixed paraffin-embedded tissue: the development of a gene expression staging system for breast carcinoma","volume":"82","author":"Baunoch","year":"2003","journal-title":"Breast Cancer Res Treat"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977605001955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977605001955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:23:27Z","timestamp":1760775807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977605001955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":108,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S0960977605001955"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2005.08.027","relation":{},"ISSN":["0960-9776"],"issn-type":[{"type":"print","value":"0960-9776"}],"subject":[],"published":{"date-parts":[[2005,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biological variables and prognosis of DCIS","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2005.08.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}